title: Ketamine abolishes ischemic preconditioning through inhibition of K(ATP) channels in rabbit hearts.
abstract: Although ketamine inhibits ATP-sensitive K (K(ATP)) channels in rat ventricular myocytes and abolishes the cardioprotective effect of ischemic preconditioning in isolated rat hearts and in rabbits in in vivo, no studies to date specifically address the precise mechanism of this prevention of ischemic preconditioning by ketamine. This study investigated the mechanism of the blockade of ischemic preconditioning by ketamine in rabbit ventricular myocytes using patch-clamp techniques and in rabbit heart slices model for simulated ischemia and preconditioning. In cell-attached and inside-out patches, ketamine inhibited sarcolemmal K(ATP) channel activities in a concentration-dependent manner. Ketamine decreased the burst duration and increased the interburst duration without a change in the single-channel conductance. In the heart slice model of preconditioning, heart slices preconditioned with a single 5-min anoxia, pinacidil, or diazoxide, followed by 15-min reoxygenation, were protected against subsequent 30-min anoxia and 1-h reoxygenation, and the cardioprotection was blocked by the concomitant presence of ketamine. These data are consistent with the notion that inhibition of sarcolemmal or mitochondrial K(ATP) channels may contribute, at least in part, to the mechanism of the blockade of ischemic preconditioning by ketamine.
authors.affiliation: Department of Physiology and Biophysics, College of Medicine, Inje University, Busan 614-735, Korea.
authors.forename: Jin
authors.initials: J
authors.lastname: Han
authors.forename: Nari
authors.initials: N
authors.lastname: Kim
authors.forename: Hyun
authors.initials: H
authors.lastname: Joo
authors.forename: Euiyong
authors.initials: E
authors.lastname: Kim
mesh_terms: D000818:Animals; D002469:Cell Separation; D019610:Cytoprotection / Q000187:drug effects / Q000502:physiology; D003981:Diazoxide / Q000494:pharmacology; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D000860:Hypoxia / Q000378:metabolism; D066298:In Vitro Techniques; D019157:Ischemic Preconditioning, Myocardial; D007649:Ketamine / Q000494:pharmacology*; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D008928:Mitochondria / Q000378:metabolism; D009206:Myocardium / Q000166:cytology / Q000378:metabolism*; D018408:Patch-Clamp Techniques; D020110:Pinacidil / Q000494:pharmacology; D015221:Potassium Channels / Q000378:metabolism*; D011817:Rabbits; D012508:Sarcolemma / Q000378:metabolism; D014665:Vasodilator Agents / Q000494:pharmacology
chemical_list: D015221:Potassium Channels; D014665:Vasodilator Agents; D007649:Ketamine; D020110:Pinacidil; D003981:Diazoxide